You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
泰格醫藥(03347.HK):向2020年A股員工持股計劃專户過户28.64萬股
格隆匯 01-15 17:10

格隆匯 1 月 15日丨泰格醫藥(03347.HK)公佈,於2021年1月15日,董事會審議並通過《關於公司回購股份專户向公司2020年A股員工持股計劃專户非交易過户轉讓股票的議案》。

公司已根據相關規定和回購條件,回購股份方案已實施完畢,公司以集中競價方式實施回購股份數量700.58萬股,成交總金額3.10億元(含交易費用),回購股份佔公司總股本的比例為1.40%,最高成交價49.50元/股,最低成交價38.50元/股,成交均價為44.25元/股。

公司董事會同意公司股份回購專户以此次回購股份成交均價44.25元/股的價格通過非交易過户方式,過户至"杭州泰格醫藥科技股份有限公司—第一期員工持股計劃"專户,過户股份共計28.64萬股。

此外,還審議並通過《關於公司2020年A股員工持股計劃選任資管機構的議案》。公司2020年A股員工持股計劃委託雲南國際信託有限公司設立的"雲南信託-泰格醫藥2020年第一期員工持股集合資金信託計劃"進行管理,股票來源系通過公司回購股份專户向此次員工持股計劃專户非交易過户轉讓股票。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account